prostate cancer
Showing NaN - NaN of 360
Breast Cancer, Colorectal Cancer, Lung Cancer Trial in New York (Questionnaires, Interviews, 30-minute telephone or
Recruiting
- Breast Cancer
- +3 more
- Questionnaires
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 8, 2023
Prostate Cancer Trial in United States (drug, device, procedure)
Recruiting
- Prostate Cancer
- Administration of IS-002
- +2 more
-
San Francisco, California
- +3 more
Jul 7, 2023
Prostate Cancer Trial in New York (Black Doctor Screening Video, White Doctor Screening Video, Black Patient Screening Video)
Completed
- Prostate Cancer
- Black Doctor Screening Video
- +7 more
-
New York, New YorkNYU Langone Health
May 24, 2023
Prostate Cancer Trial in Mineola, New York (Two-Fraction Stereotactic Body Radiation Therapy (SBRT))
Not yet recruiting
- Prostate Cancer
- Two-Fraction Stereotactic Body Radiation Therapy (SBRT)
-
Mineola, New York
- +1 more
May 9, 2023
Prostate Cancer, Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in United States (Exercise Therapy)
Recruiting
- Prostate Cancer
- +2 more
- Exercise Therapy
-
Los Angeles, California
- +7 more
Feb 20, 2023
Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)
Recruiting
- Prostate Cancer
- Docetaxel 75 mg/m2
- +2 more
-
Gilbert, Arizona
- +52 more
Feb 2, 2023
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,
Recruiting
- Prostate Cancer
- +5 more
- 177Lu-rhPSMA-10.1 injection
- 18F-rhPSMA-7.3 injection
-
Glen Burnie, Maryland
- +3 more
Feb 2, 2023
Prostate Cancer Trial in New York (89Zr- DFO-MSTP2109A, 89Zr DFO-MSTP2109A)
Active, not recruiting
- Prostate Cancer
- 89Zr- DFO-MSTP2109A
- 89Zr DFO-MSTP2109A
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 1, 2023
Prostate Disease, Elevated Prostate Specific Antigen, Family History of Prostate Cancer Trial in Lake Success, New York
Recruiting
- Prostate Disease
- +4 more
- Prostate Biopsy
- +2 more
-
Lake Success, New York
- +2 more
Jan 27, 2023
Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))
Active, not recruiting
- Prostate Cancer
- ARN-509 (Phase 1)
- ARN-509 (Phase 2)
-
San Diego, California
- +14 more
Jan 17, 2023
Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)
Active, not recruiting
- Prostate Cancer
- Prostatic Neoplasm
- abiraterone acetate in combination with prednisone
-
Homewood, Alabama
- +44 more
Jan 17, 2023
Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in United States (AZD4635, Oleclumab, Durvalumab)
Active, not recruiting
- Prostate Cancer
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- AZD4635
- +2 more
-
Denver, Colorado
- +8 more
Jan 12, 2023
Prostate Cancer Trial in New York (18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent, PET MRI Imaging)
Not yet recruiting
- Prostate Cancer
- 18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent
- PET MRI Imaging
-
New York, New YorkSmilow Comprehensive Prostate Cancer Center
Jan 9, 2023
Prostate Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Cabazitaxel)
Active, not recruiting
- Prostate Cancer
- Nivolumab
- +3 more
-
Tucson, Arizona
- +59 more
Dec 22, 2022
Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)
Recruiting
- Small Cell Lung Cancer
- +8 more
- ladiratuzumab vedotin
- pembrolizumab
-
Chandler, Arizona
- +65 more
Dec 19, 2022
Body Composition and White Adipose Tissue Inflammation
Active, not recruiting
- Breast Cancer
- +3 more
- DEXA Scan
- Godin Leisure Time Exercise Questionnaire (GLTEQ)
-
Milford, Massachusetts
- +7 more
Dec 19, 2022
Prostate Cancer Trial in United States (Abiraterone Acetate, Prednisone 5Mg Tab, DST-2970 (Abiraterone))
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
- +2 more
-
Miami, Florida
- +4 more
Dec 14, 2022
Prostate Cancer Trial in Canada, United States (Enzalutamide, EPI-7386 with Enzalutamide)
Recruiting
- Prostate Cancer
- Enzalutamide
- EPI-7386 with Enzalutamide
-
Port Saint Lucie, Florida
- +8 more
Dec 13, 2022
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in Worldwide (acapatamab, Pembrolizumab, Etanercept)
Active, not recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- acapatamab
- +3 more
-
Campbell, California
- +29 more
Dec 6, 2022
Prostate Cancer Trial in United States (TAK-700, Bicalutamide)
Active, not recruiting
- Prostate Cancer
-
Birmingham, Alabama
- +559 more
Dec 5, 2022
Prostate Cancer Trial in New Orleans, New York (225Ac-J591)
Active, not recruiting
- Prostate Cancer
-
New Orleans, Louisiana
- +1 more
Nov 15, 2022
Prostate Cancer Trial in United States (abiraterone acetate, Prednisone)
Active, not recruiting
- Prostate Cancer
- abiraterone acetate
- Prednisone
-
Jonesboro, Arkansas
- +204 more
Nov 30, 2022
Prostate Cancer Trial in New York (engineered autologous T cells, cyclophosphamide)
Active, not recruiting
- Prostate Cancer
- engineered autologous T cells
- cyclophosphamide
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 28, 2022